A medication can be the right choice and still never get taken. That’s not a science problem. It’s a human one and it’s why we’re starting a conversation about the part of psychopharmacology that rarely shows up in a clinical trial: the lived experience of care.

I’m Dr. Sondra Jan, and I’m launching The Human Side of Psychopharmacology with one guiding belief: every encounter is therapeutic. After decades of work alongside psychiatric prescribers, therapists, patients, and families, I keep coming back to the same question: what helps treatment stick after the appointment ends? We talk about how trust is built, how hope is protected, and how uncertainty can be navigated without losing the person sitting across from us.

Mental health care is moving quickly toward precision medicine, digital tools, biomarkers, AI, and new therapies. I love that progress but I also worry about what gets lost when speed and innovation crowd out connection. The future of psychiatric care is both better treatments and better experiences of treatment, because engagement, shared decision making, and the clinician patient relationship shape adherence and outcomes.

You’ll hear real clinical stories that reveal the hidden gap between the treatment plan and real life: the patient who agrees with the diagnosis but never starts the medication because she’s scared, and the patient who stops an antidepressant in silence due to sexual side effects and embarrassment. If you want practical ways to make it safer for patients to tell the truth, ask the questions they can’t quite say, and keep hope alive when treatment gets hard, you’re in the right place. Subscribe, share this with a colleague, and leave a review so more clinicians can build care that patients actually experience as healing.